BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16236086)

  • 1. Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control.
    Bailey CJ; Del Prato S; Eddy D; Zinman B;
    Int J Clin Pract; 2005 Nov; 59(11):1309-16. PubMed ID: 16236086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
    Akalin S; Berntorp K; Ceriello A; Das AK; Kilpatrick ES; Koblik T; Munichoodappa CS; Pan CY; Rosenthall W; Shestakova M; Wolnik B; Woo V; Yang WY; Yilmaz MT;
    Int J Clin Pract; 2009 Oct; 63(10):1421-5. PubMed ID: 19769698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New global recommendations: a multidisciplinary approach to improving outcomes in diabetes.
    McGill M; Felton AM;
    Prim Care Diabetes; 2007 Feb; 1(1):49-55. PubMed ID: 18632019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.
    Lebovitz HE
    J Indian Med Assoc; 2008 Nov; 106(11):724-6. PubMed ID: 19368098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. We have the evidence, we need to act to improve diabetes care.
    Del Prato S; Horton E; Nesto R;
    Int J Clin Pract Suppl; 2007 Dec; (157):9-15. PubMed ID: 17991186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.
    Guo LX; Pan Q; Wang XX; Li H; Zhang LN; Chi JM; Wang Y
    Chin Med J (Engl); 2008 Apr; 121(8):687-90. PubMed ID: 18701019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management.
    Del Prato S; Felton AM; Munro N; Nesto R; Zimmet P; Zinman B;
    Int J Clin Pract Suppl; 2007 Dec; (157):47-57. PubMed ID: 18087796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
    Crasto W; Jarvis J; Khunti K; Davies MJ
    Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ; Zrebiec J
    Diabetes Metab Res Rev; 2008; 24(4):257-85. PubMed ID: 18232062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
    Barnett A
    Int J Clin Pract Suppl; 2007 Aug; (154):12-8. PubMed ID: 17593273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
    Tibaldi J; Rakel RE
    Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining insulin therapy in type 2 diabetes mellitus.
    Rosenstock J
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):21-9. PubMed ID: 19667676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of beta-cell management in type 2 diabetes.
    Standl E
    Int J Clin Pract Suppl; 2007 Jun; (153):10-9. PubMed ID: 17594389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive therapy for diabetes through influence on innate immune system.
    Li ZZ; Liu JB; Li L; Jiao L; Chen L
    Med Hypotheses; 2009 Jun; 72(6):675-6. PubMed ID: 19264419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes mellitus: new evidence, more controversy.
    Green D
    Mt Sinai J Med; 2009 Jun; 76(3):215. PubMed ID: 19421964
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes and dyslipidaemia.
    Schwartz SL
    Diabetes Obes Metab; 2006 Jul; 8(4):355-64. PubMed ID: 16776742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategy for patient management with type 2 diabetes excepting care of complications. Recommendations of ANAES--March 2000].
    Charbonnel B
    Diabetes Metab; 2000 May; 26(3):232-43. PubMed ID: 10880899
    [No Abstract]   [Full Text] [Related]  

  • 20. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.